535 related articles for article (PubMed ID: 15061959)
1. [Effects of sustained release morphine hydrochloride tablets in management of cancer pain: a survey of 567 patients].
Yu SY; Qiu H; Ma ZS; Chen J; Zhang Y; Chen LZ; Wang DL; Ma ZY
Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):450-5. PubMed ID: 15061959
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy comparison between morphine sulfate controlled-released tablet and morphine hydrochloride sustained-released tablet in treating cancer pain].
Yao WX; Zhou H; Wang LY; Wei Y; Liu XY
Ai Zheng; 2007 Dec; 26(12):1357-9. PubMed ID: 18076801
[TBL] [Abstract][Full Text] [Related]
3. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
[TBL] [Abstract][Full Text] [Related]
4. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain.
van Seventer R; Smit JM; Schipper RM; Wicks MA; Zuurmond WW
Curr Med Res Opin; 2003; 19(6):457-69. PubMed ID: 14594516
[TBL] [Abstract][Full Text] [Related]
5. [Transdermal fentanyl for the management of cancer pain: a survey of 1,664 elderly patients].
Yu SY; Sun Y; Zhang HC; Wu YL; Qin SK; Xie GR; Liu SJ; Sui G
Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(22):1931-5. PubMed ID: 14703423
[TBL] [Abstract][Full Text] [Related]
6. [Feasibility to treat pediatric cancer pain with analgesics for adults and their efficacy].
Zhen ZJ; Sun XF; Xia Y; Ling JY; Zheng L; Luo WB; Lin H
Ai Zheng; 2007 Aug; 26(8):866-9. PubMed ID: 17697549
[TBL] [Abstract][Full Text] [Related]
7. [Transdermal fentanyl for the management of cancer pain: a survey of 4492 patients].
Yu SY; Sun Y; Wu YL; Qin SK; Xie GR; Liu SJ; Sui GJ; Zhang HC
Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):369-72. PubMed ID: 16117902
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of TD-fentanyl with sustained-release morphine in the pain treatment of patients with lung cancer].
Oztürk T; Karadibak K; Catal D; Cakan A; Tugsavul F; Cirak K
Agri; 2008 Jul; 20(3):20-5. PubMed ID: 19085178
[TBL] [Abstract][Full Text] [Related]
9. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
10. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
Clark AJ; Ahmedzai SH; Allan LG; Camacho F; Horbay GL; Richarz U; Simpson K
Curr Med Res Opin; 2004 Sep; 20(9):1419-28. PubMed ID: 15383190
[TBL] [Abstract][Full Text] [Related]
12. Codeine/acetaminophen and hydrocodone/acetaminophen combination tablets for the management of chronic cancer pain in adults: a 23-day, prospective, double-blind, randomized, parallel-group study.
Rodriguez RF; Castillo JM; Del Pilar Castillo M; Nuñez PD; Rodriguez MF; Restrepo JM; Rodriguez JM; Ortiz Y; Angel AM
Clin Ther; 2007 Apr; 29(4):581-7. PubMed ID: 17617281
[TBL] [Abstract][Full Text] [Related]
13. [Long-term therapy of tumor pain using morphine-retard tablets].
Sorge J; Lehmkuhl C; Lohse K; Herrmann H; Pichlmayr I
Med Klin (Munich); 1990 Sep; 85(9):523-8. PubMed ID: 2233610
[TBL] [Abstract][Full Text] [Related]
14. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study.
Bruera E; Palmer JL; Bosnjak S; Rico MA; Moyano J; Sweeney C; Strasser F; Willey J; Bertolino M; Mathias C; Spruyt O; Fisch MJ
J Clin Oncol; 2004 Jan; 22(1):185-92. PubMed ID: 14701781
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, multi-site, crossover, placebo-controlled equivalence study of morning versus evening once-daily sustained-release morphine sulfate in people with pain from advanced cancer.
Currow DC; Plummer JL; Cooney NJ; Gorman D; Glare PA
J Pain Symptom Manage; 2007 Jul; 34(1):17-23. PubMed ID: 17601560
[TBL] [Abstract][Full Text] [Related]
16. Pain management of opioid-treated cancer patients in hospital settings in Denmark.
Lundorff L; Peuckmann V; Sjøgren P
Acta Anaesthesiol Scand; 2008 Jan; 52(1):137-42. PubMed ID: 18005379
[TBL] [Abstract][Full Text] [Related]
17. Experience with a controlled-release oral morphine for cancer pain management.
Kim BS; Chung HC
Postgrad Med J; 1991; 67 Suppl 2():S82-6. PubMed ID: 1758823
[TBL] [Abstract][Full Text] [Related]
18. The MERITO Study: a multicentre trial of the analgesic effect and tolerability of normal-release oral morphine during 'titration phase' in patients with cancer pain.
De Conno F; Ripamonti C; Fagnoni E; Brunelli C; Luzzani M; Maltoni M; Arcuri E; Bertetto O;
Palliat Med; 2008 Apr; 22(3):214-21. PubMed ID: 18477715
[TBL] [Abstract][Full Text] [Related]
19. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
[TBL] [Abstract][Full Text] [Related]
20. Long-acting morphine for pain control in paediatric oncology.
Zernikow B; Lindena G
Med Pediatr Oncol; 2001 Apr; 36(4):451-8. PubMed ID: 11260568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]